AGP Picks
View all

Nutrition BioTech details what bulk NMN buyers should demand on a COA

Nov. 16, 2026
Nutrition BioTech details what bulk NMN buyers should demand on a COA
By AI, Created 18:06 UTC, Nov 16, 2026, AGP -

Nutrition BioTech has published a guide for supplement brands and contract manufacturers showing how NMN production routes change impurity testing and what a lot-specific COA should include before purchase. The company also lists bulk NMN availability, quality documents and ordering terms for buyers.

Why it matters: - Bulk NMN powder can look identical on paper even when it comes from different production routes. - A simple assay figure such as "β-NMN, 99%" does not show how the material was made or which impurities were tested. - For buyers, that can affect purity review, sourcing decisions and documentation before an order is placed.

What happened: - Nutrition BioTech, also known as NaturalBestBio, released a guide on Nov. 1, 2026 explaining NMN production routes and certificates of analysis for supplement brands and contract manufacturers. - The guide says buyers should ask which route produced the quoted lot before comparing prices. - The company also published buyer resources on NMN production routes and NMN specifications. - The guide is aimed at bulk NMN powder buyers.

The details: - The guide describes three commercial production routes: chemical synthesis, cell-free enzymatic synthesis and whole-cell fermentation. - Chemical synthesis can form both α- and β-anomers, which then must be separated. - Enzymatic and fermentation routes start from nicotinamide and use enzymes or engineered microbes. - For biological routes, buyers should check residual starting material and evidence that enzyme protein or host-cell material has been removed. - The guide says buyers should look for nicotinamide, nicotinamide riboside and niacin as separate lines on the COA, each with a numeric limit. - As a reference point, the guide cites a compositional guideline from Australia's Therapeutic Goods Administration for one enzymatically produced NMN material. - That guideline sets separate limits for those three compounds, any other single impurity and total impurities. - The guide says that reference is one regulator's specification for one material, not a universal standard. - Nicotinamide can be a starting material in biological routes and can also form when NMN breaks down. - A high nicotinamide result can therefore reflect purification conditions or storage history. - The guide's five-point COA check asks buyers to verify identity, assay, related compounds, process residues and traceability. - Identity should include CAS 1094-61-7, confirmation beyond HPLC retention time and structural confirmation of the β-anomer. - Assay should list the value, the method and the reference standard. - Related compounds should show three separate results with limits. - Process residues should name residual solvents and, for biological routes, include a statement on enzyme and host-cell removal. - Traceability should include the lot number, manufacturing date, test date and issuing laboratory. - The guide says a missing line is a documentation gap to resolve with the supplier, not proof that the material fails. - The company's bulk NMN powder is β-nicotinamide mononucleotide, CAS 1094-61-7, with an assay of not less than 99.0% by HPLC. - Nutrition BioTech says ready stock is held in the United States. - The minimum order is 1 kg. - Packaging is 25 kg per drum. - Dispatch is within three working days of purchase order, excluding carrier transit time. - The company's quality system includes ISO 22000:2018, FSSC 22000 and HACCP, with certificates available on request. - Nutrition BioTech says it maintains product liability insurance and cargo insurance, subject to policy terms and shipment arrangements. - The company says an NDI notification for the NMN it supplies has been submitted to the FDA, and notification documents are available to qualified buyers on request. - Every lot ships with a lot-specific Certificate of Analysis. - Nutrition BioTech says its public specification sheet is not a batch COA, and lot COAs and supporting records are available for qualified buyer review before purchase. - The company lists more information on NMN production routes and COA impurities and NMN specifications and sample requests.

Between the lines: - The guide positions documentation quality as part of product quality, not just a paperwork exercise. - By splitting impurities and process residues into separate checks, the company is signaling that buyers should compare more than price and assay. - The emphasis on route-specific testing reflects a broader shift toward tighter sourcing review for nutraceutical ingredients.

What's next: - Buyers are expected to use route disclosure and lot-specific COAs to screen suppliers before ordering. - Nutrition BioTech says qualified buyers can request certificates, notification documents and supporting records before purchase. - The company says lot-specific COAs ship with every batch, which gives buyers a document trail to review alongside the specification sheet.

The bottom line: - For NMN buyers, the key question is no longer just whether the powder assays at 99%; it is whether the COA shows how the lot was made and what else was tested.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Transportation Industry News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Transportation Industry News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.